Headline Details

Drugmakers see a pricing blueprint in an $850,000 gene therapy

Published on: Fri, 12 Jan 2018 20:32:34 UTC
News Agency: Reuters
Description:
SAN FRANCISCO (Reuters) - Global drugmakers are looking to a tiny biotech's $850,000 therapy for a rare type of blindness as a model for getting paid for highly expensive – and effective – new medicines.

Click here for FULL Story on Reuters

Also happening now

HeadlineNews Agency
U.S. Embassy in Israel to move to Jerusalem by end of 2019: Pence Reuters
Explainer: Britain's Lords sharpen knives for EU exit laws, but can they block Brexit? Reuters
Abbas wins EU backing for Palestinian capital in East Jerusalem Reuters
Italy's 5-Star presents election program with no euro referendum Reuters
Australia police in fresh search for missing Beaumont children BBC